Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0326 | ||||
Gene Name | SLC38A1 | ||||
Protein Name | Sodium-coupled neutral amino acid transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | ATA1; Amino acid transporter A1; N-system amino acid transporter 2; NAT2; SLC38A1; SNAT1; Solute carrier family 38 member 1; System A amino acid transporter 1; System N amino acid transporter 1 | ||||
DT Family | Amino Acid/Auxin Permease (AAAP) Family ; | ||||
Tissue Specificity | Expressed in the cerebral cortex by pyramidaland GABAergic neurons, astrocytes and other non-neuronal cells (atprotein level). Expressed in placenta, heart, lung, skeletalmuscle, spleen, stomach and testis. | ||||
Function | This sodium-dependent amino acid transporter mediates the saturable, pH-sensitive and electrogenic cotransport of glutamine and sodium ions with a stoichiometry of 1:1. May also transport small zwitterionic and aliphatic amino acids with a lower affinity. May supply glutamatergic and GABAergic neurons with glutamine which is required for the synthesis of the neurotransmitters glutamate and GABA. | ||||
Disease(s) | Short bowel syndrome [ICD-11: KB89.1] | ||||
Endogenous Substrate(s) | Glutamine; Sodium ions; Zwitterionic amino acids; Aliphatic amino acids | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 2 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
L-alanine
|
Approved | Drug Info | Glioma | 2A00.0 | [1] |
L-glutamine
|
Approved | Drug Info | Short bowel syndrome | KB89.1 | [1] |
Endogenous Metabolites (EMs) Handled by This DT |
|||||
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 1 EMs in Total | ||||
EM Name | PubChem CID | Detail | Experimental Material | Ref | |
Alanine | EM Info | Identified using SNAT1 knockout T-cells | [2] | ||
References | |||||
1 | Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons. J Biol Chem. 2011 Jun 10;286(23):20500-11. | ||||
2 | Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef. Cell Host Microbe. 2015 Oct 14;18(4):409-23. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.